Alerts

The purpose of this notification is to advise stakeholders that from Friday, 13 January 2023 the department will add Therapeutic Goods Administration (TGA) approved medicinal cannabis plant parts other than seed products to the exclusions in the list of other-risk plant products (including mode of arrival and end use) for host of khapra beetle. This will remove the requirement for a phytosanitary certificate for, TGA approved medicinal cannabis plant parts other than seed, including the additional declaration:

“Representative samples were inspected and found free from evidence of any species of Trogoderma (whether live, dead or exuviae) in Australia’s list of Trogoderma species of biosecurity concern”.

Background:
The list of other-risk plant products (including mode of arrival and end use) for host of khapra beetle already excludes several highly refined, commercially prepared and packaged plant products. Given the high level of processing and existing regulation administered by the TGA, the department can exclude TGA approved medicinal cannabis plant parts other than seed from the requirements for other-risk plant products to protect against khapra beetle (Phase 4) while continuing to achieve Australia’s appropriate level of protection.

Who does this alert affect?
Importers (and their customs brokers) of TGA approved medicinal cannabis plant parts other than seed products and department staff.

Further information:
Please contact Plant Import Operations on 1800 900 090 or email imports@agriculture.gov.au (please title the subject line of the email ‘Plant Tier 2 – Plant products for human consumption’).